Results indicate that elevated levels of circulating inflammatory cytokines IL-2, IL-17, IL-18, and IFN-γ are related to enhanced risk of psoriasis and may help to predict clinical outcomes in individuals with psoriasis. This evidence concerns the gene IFNG and psoriasis.